Accessibility Menu
Emergent BioSolutions Stock Quote

Emergent BioSolutions (NYSE: EBS)

$9.43
(-0.2%)
-0.02
Price as of October 22, 2025, 4:00 p.m. ET

KEY DATA POINTS

Current Price
$9.43
Daily Change
(-0.2%) $0.02
Day's Range
$9.13 - $9.54
Previous Close
$9.43
Open
$9.45
Beta
1.76
Volume
615,963
Average Volume
1,115,225
Market Cap
504.2M
Market Cap / Employee
$9.45M
52wk Range
$4.02 - $12.73
Revenue
-
Gross Margin
0.46%
Dividend Yield
N/A
EPS
$2.45
CAPs Rating
-
Industry
Biotechnology

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Emergent BioSolutions Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
EBS-7.17%-90.32%-37.32%-14%
S&P+15.06%+95.03%+14.29%+382%

Emergent BioSolutions Company Info

Emergent BioSolutions makes the only FDA-approved anthrax vaccine.

News & Analysis

The Fool has written over 100 articles on Emergent BioSolutions.

Financial Health

General

Q2 2025YOY Change
Revenue$140.90M-44.7%
Gross Profit$57.50M205.5%
Gross Margin40.81%62.2%
Market Cap$346.29M-3.1%
Market Cap / Employee$0.38M0.0%
Employees900-43.7%
Net Income-$12.00M95.8%
EBITDA$24.50M118.9%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q2 2025YOY Change
Net Cash$271.00M281.7%
Accounts Receivable$79.80M-59.3%
Inventory338.66.6%

Liabilities

Q2 2025YOY Change
Long Term Debt$674.30M47.1%
Short Term Debt$1.80M-99.6%

Ratios

Q2 2025YOY Change
Return On Assets9.52%41.3%
Return On Invested Capital-14.86%-3.9%

Cash Flow

Q2 2025YOY Change
Free Cash Flow$103.50M141.3%
Operating Free Cash Flow$106.40M124.0%

Valuation

MetricQ2 2025YoY Change
Price to Earnings2.60-
Price to Book1.141.020.550.6316.87%
Price to Sales0.410.500.290.4124.76%
Price to Tangible Book Value-2.99-55.02-14.115.1563.61%
Price to Free Cash Flow TTM3.3614.472.952.23-76.62%
Enterprise Value to EBITDA10.0567.6210.7030.65-441.35%
Free Cash Flow Yield29.7%6.9%33.9%44.8%327.66%
Return on Equity-34.6%-33.7%-21.6%30.2%-134.59%
Total Debt$676.00M$676.10M$672.70M$676.10M-22.89%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.